Cancer-related mortality among people with intellectual disabilities: A nationwide population-based cohort study
- PMID: 34787906
- PMCID: PMC9299498
- DOI: 10.1002/cncr.34030
Cancer-related mortality among people with intellectual disabilities: A nationwide population-based cohort study
Abstract
Background: Concerns have been raised about access to cancer screening and the timely receipt of cancer care for people with an intellectual disability (ID). However, knowledge about cancer mortality as a potential consequence of these disparities is still limited. This study, therefore, compared cancer-related mortality patterns between people with and without ID.
Methods: A historical cohort study (2015-2019) linked the Dutch adult population (approximately 12 million people with an ID prevalence of 1.45%) and mortality registries. Cancer-related mortality was identified by the underlying cause of death (according to the chapter on neoplasms in the International Classification of Diseases, Tenth Revision). Observed mortality and calculated age- and sex-standardized mortality ratios (SMRs) with 95% confidence intervals (CIs) were reported.
Results: There were 11,102 deaths in the ID population (21.7% cancer-related; n = 2408) and 730,405 deaths in the general population (31.2%; n = 228,120) available for analysis. Cancer was noted as the cause of death more often among people with ID in comparison with the general population (SMR, 1.48; 95% CI, 1.42-1.54), particularly in the young age groups. High-mortality cancers included cancers within the national screening program (SMRs, 1.43-1.94), digestive cancers (SMRs, 1.24-2.56), bladder cancer (SMR, 2.07; 95% CI, 1.61-2.54), and cancers of unknown primary (SMR, 2.48; 95% CI, 2.06-2.89).
Conclusions: Cancer was reported as the cause of death approximately 1.5 times more often in people with ID compared with the general population. This mortality disparity may indicate adverse effects from inequalities in screening and cancer care experienced by people with ID.
Lay summary: People with an intellectual disability (ID) may find it challenging to participate in cancer screening or to receive timely cancer care. To understand potential consequences in terms of mortality, this study compared cancer-related mortality between people with and without ID in the Netherlands. Cancer was reported as the cause of death approximately 1.5 times more often among people with ID than others. Because large differences were found that were related to screening cancers and cancers for which the primary tumor was unknown, this study's results raise concerns about equality in screening practices and cancer care for people with ID.
Keywords: cancer; cause of death; disparities; intellectual disability; population-based; standardized mortality ratio.
© 2021 The Authors. Cancer published by Wiley Periodicals LLC on behalf of American Cancer Society.
Conflict of interest statement
Geraline L. Leusink is a member of the board of directors for the Maastricht University Medical Center. The other authors made no disclosures.
Similar articles
-
All-cause and cause-specific mortality among people with and without intellectual disabilities during the COVID-19 pandemic in the Netherlands: a population-based cohort study.Lancet Public Health. 2023 May;8(5):e356-e363. doi: 10.1016/S2468-2667(23)00062-2. Epub 2023 Apr 16. Lancet Public Health. 2023. PMID: 37075779 Free PMC article.
-
Mortality of people with intellectual disabilities during the 2017/2018 influenza epidemic in the Netherlands: potential implications for the COVID-19 pandemic.J Intellect Disabil Res. 2020 Jul;64(7):482-488. doi: 10.1111/jir.12739. Epub 2020 May 26. J Intellect Disabil Res. 2020. PMID: 32458565 Free PMC article.
-
Cause-specific mortality and death certificate reporting in adults with moderate to profound intellectual disability.J Intellect Disabil Res. 2009 Nov;53(11):898-904. doi: 10.1111/j.1365-2788.2009.01201.x. Epub 2009 Aug 18. J Intellect Disabil Res. 2009. PMID: 19694898
-
Respiratory-associated deaths in people with intellectual disabilities: a systematic review and meta-analysis.BMJ Open. 2021 Jul 14;11(7):e043658. doi: 10.1136/bmjopen-2020-043658. BMJ Open. 2021. PMID: 34261677 Free PMC article.
-
Incidence and prevalence of falls in adults with intellectual disability living in the community: a systematic review.JBI Database System Rev Implement Rep. 2019 Mar;17(3):390-413. doi: 10.11124/JBISRIR-2017-003798. JBI Database System Rev Implement Rep. 2019. PMID: 30870331
Cited by
-
Early-onset stroke among people with disabilities: a national database study in South Korea from 2008 to 2017.Lancet Reg Health West Pac. 2023 Jun 13;38:100819. doi: 10.1016/j.lanwpc.2023.100819. eCollection 2023 Sep. Lancet Reg Health West Pac. 2023. PMID: 37790075 Free PMC article.
-
[Cancer in people with an intellectual disability in Germany: prevalence, genetics, and care situation].Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024 Mar;67(3):362-369. doi: 10.1007/s00103-024-03837-1. Epub 2024 Feb 9. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz. 2024. PMID: 38334785 Free PMC article. Review. German.
-
Disparities in All-Cause Mortality in Older Patients with Colorectal Cancer According to Disability Status: A Nationwide Analysis.Curr Oncol. 2022 Oct 5;29(10):7430-7438. doi: 10.3390/curroncol29100584. Curr Oncol. 2022. PMID: 36290861 Free PMC article.
-
Impact of Disability Status on Mortality in Patients with Gastric Cancer: A Nationwide Study Focusing on Regional Disparities.Healthcare (Basel). 2023 Feb 21;11(5):641. doi: 10.3390/healthcare11050641. Healthcare (Basel). 2023. PMID: 36900646 Free PMC article.
-
Breast (female), colorectal, and lung cancer survival in people with intellectual or developmental disabilities: A population-based retrospective cohort study.Can J Public Health. 2024 Apr;115(2):332-342. doi: 10.17269/s41997-023-00844-8. Epub 2024 Feb 5. Can J Public Health. 2024. PMID: 38315327 Free PMC article.
References
-
- Torre LA, Siegel RL, Ward EM, Jemal A. Global cancer incidence and mortality rates and trends—an update. Cancer Epidemiol Biomarkers Prev. 2016;25:16‐27. - PubMed
-
- Hashim D, Boffetta P, La Vecchia C, et al. The global decrease in cancer mortality: trends and disparities. Ann Oncol. 2016;27:926‐933. - PubMed
-
- Hill DA, Gridley G, Cnattingius S, et al. Mortality and cancer incidence among individuals with Down syndrome. JAMA Intern Med. 2003;163:705‐711. - PubMed
-
- Hogg J, Tuffrey‐Wijne I. Cancer and intellectual disability: a review of some key contextual issues. J Appl Res Intellect Disabil. 2008;21:509‐518.
-
- Rubin G, Berendsen A, Crawford SM, et al. The expanding role of primary care in cancer control. Lancet Oncol. 2015;16:1231‐1272. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical